What is it about?
Based on national retail pharmacy data, psychotropic medication prescriptions declined in children and adolescents shortly after the start of the COVID-19 pandemic. Medications approached pre-pandemic levels by September 2020, with the magnitude of change varying by medication class and across US geographical region.
Featured Image
Read the Original
This page is a summary of: Geographic Trends in Pediatric Psychotropic Medication Dispensing Before and After the Start of the COVID-19 Pandemic, Psychiatric Services, August 2023, American Psychiatric Association,
DOI: 10.1176/appi.ps.20220314.
You can read the full text:
Contributors
The following have contributed to this page
